메뉴 건너뛰기




Volumn 136, Issue 10, 2017, Pages 969-972

Effect of empagliflozin on the metabolic signature of patients with type 2 diabetes mellitus and cardiovascular disease

Author keywords

Branched chain amino acids; Cardiovascular disease; Empagliflozin; Ketone bodies; Metabolomics; SGTL2 inhibitors; Type 2 diabetes mellitus

Indexed keywords

BRANCHED CHAIN AMINO ACID; EMPAGLIFLOZIN; GLUCAGON; GLUCOSE; ISOLEUCINE; KETONE BODY; LEUCINE; VALINE; BENZHYDRYL DERIVATIVE; BIOLOGICAL MARKER; GLUCOSIDE;

EID: 85031040731     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.029166     Document Type: Letter
Times cited : (123)

References (5)
  • 2
    • 84994798393 scopus 로고    scopus 로고
    • Evolving concepts of myocardial energy metabolism: More than just fats and carbohydrates
    • Lopaschuk GD, Ussher JR. Evolving concepts of myocardial energy metabolism: more than just fats and carbohydrates. Circ Res. 2016;119:1173-1176. doi: 10.1161/CIRCRESAHA. 116.310078.
    • (2016) Circ Res , vol.119 , pp. 1173-1176
    • Lopaschuk, G.D.1    Ussher, J.R.2
  • 3
    • 84975853831 scopus 로고    scopus 로고
    • Thrifty substrate; Hypothesis
    • Ferrannini E, Mark M, Mayoux E. CV Protection in the EMPA-REG OUTCOME trial: a "thrifty substrate" hypothesis. Diabetes Care. 2016;39:1108-1114. doi: 10.2337/dc16-0330.
    • (2016) Diabetes Care , vol.39 , pp. 1108-1114
    • Ferrannini, E.1    Mark, M.2
  • 4
    • 84975840750 scopus 로고    scopus 로고
    • Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPAREG OUTCOME study? A unifying hypothesis
    • Mudaliar S, Alloju S, Henry RR. Can a shift in fuel energetics explain the beneficial cardiorenal outcomes in the EMPAREG OUTCOME study? A unifying hypothesis. Diabetes Care. 2016;39:1115-1122. doi: 10.2337/dc16-0542.
    • (2016) Diabetes Care , vol.39 , pp. 1115-1122
    • Mudaliar, S.1    Alloju, S.2    Henry, R.R.3
  • 5
    • 84975775436 scopus 로고    scopus 로고
    • Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure
    • Bedi KC Jr, Snyder NW, Brandimarto J, Aziz M, Mesaros C, Worth AJ, Wang LL, Javaheri A, Blair IA, Margulies KB, Rame JE. Evidence for intramyocardial disruption of lipid metabolism and increased myocardial ketone utilization in advanced human heart failure. Circulation. 2016;133:706-716. doi: 10.1161/CIRCULATIONAHA. 115.017545.
    • (2016) Circulation , vol.133 , pp. 706-716
    • Snyder, N.W.1    Brandimarto, J.2    Aziz, M.3    Mesaros, C.4    Worth, A.J.5    Wang, L.L.6    Javaheri, A.7    Blair, I.A.8    Margulies, K.B.9    Rame, J.E.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.